Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1967 1
1968 4
1969 8
1970 6
1971 3
1972 7
1973 5
1974 6
1975 3
1976 7
1978 1
1980 1
1982 3
1983 5
1984 3
1985 1
1986 4
1987 3
1988 4
1989 7
1990 8
1991 6
1992 11
1993 8
1994 13
1995 13
1996 7
1997 12
1998 10
1999 12
2000 18
2001 26
2002 21
2003 21
2004 50
2005 38
2006 60
2007 77
2008 87
2009 79
2010 95
2011 86
2012 126
2013 124
2014 128
2015 120
2016 113
2017 122
2018 141
2019 122
2020 152
2021 162
2022 139
2023 105
2024 111
2025 130
2026 75

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,292 results

Results by year

Filters applied: . Clear all
Page 1
Sex-specific vulnerabilities in cannabis-induced psychosis: A scoping review.
Ricci V, Berardis D, Martinotti G, Maina G. Ricci V, et al. Asian J Psychiatr. 2026 Jul 8;122:105086. doi: 10.1016/j.ajp.2026.105086. Online ahead of print. Asian J Psychiatr. 2026. PMID: 42424782 Review.
BACKGROUND: Cannabis-induced psychosis presents complex sex-based disparities that challenge traditional epidemiological patterns. While males demonstrate higher cannabis use rates, emerging evidence reveals paradoxical vulnerability patterns where females may show …
BACKGROUND: Cannabis-induced psychosis presents complex sex-based disparities that challenge traditional epidemiological patterns. Wh …
How clinicians think about dual disorders: Insights from a case vignette survey.
Singh R, Sarkar S, Meena O, Balhara YPS. Singh R, et al. Indian J Psychiatry. 2026 May;68(5):456-459. doi: 10.4103/indianjpsychiatry_765_25. Epub 2026 May 19. Indian J Psychiatry. 2026. PMID: 42381850 Free PMC article.
METHODS: This Cross-sectional study surveyed 73 mental health professionals using two clinical vignettes that depicted common dual disorder scenarios: psychotic symptoms co-occurring with cannabis use and depressive symptoms co-occurring with alcohol use. Participants chos …
METHODS: This Cross-sectional study surveyed 73 mental health professionals using two clinical vignettes that depicted common dual disorder …
Systematic Review and Meta-Analysis: Prevalence, Correlates, and Impact of Cannabis Use and Cannabis Use Disorder in Early-Onset Psychosis.
Salazar de Pablo G, Laherran-Cantera N, Aymerich C, Galvañ J, Palacios-Garrán R, Armyra E, Pedruzo B, Lahera G, Catalán A, Díaz-Caneja CM, Calvo A, Arango C, Di Forti M, Murray RM, Correll CU. Salazar de Pablo G, et al. J Am Acad Child Adolesc Psychiatry. 2026 Jun 22:S0890-8567(26)00277-7. doi: 10.1016/j.jaac.2026.06.012. Online ahead of print. J Am Acad Child Adolesc Psychiatry. 2026. PMID: 42331312 Free article.
OBJECTIVE: To quantify the prevalence of cannabis use (CU) and cannabis use disorders (CUD) in Early-Onset Psychosis (EOP; <18 years) and examine their correlates, clinical and functional impact. ...In meta-regression analyses, current CU was associated with male …
OBJECTIVE: To quantify the prevalence of cannabis use (CU) and cannabis use disorders (CUD) in Early-Onset Psychosis (EOP; &lt …
Patterns of onset and progression of psychoses induced by psychoactive substance use.
Ifteni P, Miron AA, Necula R, Dima L, Teodorescu A. Ifteni P, et al. Psychiatry Res. 2026 Jun 15;364:117283. doi: 10.1016/j.psychres.2026.117283. Online ahead of print. Psychiatry Res. 2026. PMID: 42320288
RESULTS: Of all admissions, 2353 (9.6%) were diagnosed with acute psychotic disorders, of which 129 (5.5%) were related to psychoactive substances. THC (cannabis) was the main substance used, being present in 82.95% of cases. Almost half of the patients (44.96%) reported m …
RESULTS: Of all admissions, 2353 (9.6%) were diagnosed with acute psychotic disorders, of which 129 (5.5%) were related to psychoactive subs …
Knowledge about the health effects of cannabis before and after legalization of 'recreational' cannabis in Canada: findings from the International Cannabis Policy Study, 2018-2024.
Tong W, Hammond D. Tong W, et al. J Cannabis Res. 2026 Jun 10. doi: 10.1186/s42238-026-00428-6. Online ahead of print. J Cannabis Res. 2026. PMID: 42271472 Free article.
BACKGROUND: Although prior research has examined how cannabis legal status relates to psychosocial predictors of use, less is known about whether recreational legalization influences public knowledge of specific cannabis-related health effects. This study addresses …
BACKGROUND: Although prior research has examined how cannabis legal status relates to psychosocial predictors of use, less is known a …
Nationwide time trends in co-occurring mental illness and substance use disorders among adolescents and young adults: differences in diagnoses, age, sex, and educational attainment between 2010 and 2022.
Skou Jakobsen J, Johansen KS, Thylstrup B, Mårtensson S. Skou Jakobsen J, et al. Nord J Psychiatry. 2026 Jul;80(5):299-307. doi: 10.1080/08039488.2026.2680604. Epub 2026 Jun 7. Nord J Psychiatry. 2026. PMID: 42251533
When distributed by sex, age and diagnoses, dual diagnosis was most frequently occurring among males; young adults (ages 22-25); adolescents and young adults with schizophrenia, schizotypal and delusional disorders; neurotic, stress-related and somatoform disorders; as wel …
When distributed by sex, age and diagnoses, dual diagnosis was most frequently occurring among males; young adults (ages 22-25); adolescents …
Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis With or Without Cannabis Exposure.
D'Souza DC, Cortes-Briones J, Raj J, Ganesh S, Vidya KL, Krishna Tikka S, Shreekantiah U, Singh N, Murthy P, Urrutia-Gandolfo J, Ram D, Sharma P, Sinha VK, Goyal N. D'Souza DC, et al. Am J Psychiatry. 2026 Jun 3:appiajp20250726. doi: 10.1176/appi.ajp.20250726. Online ahead of print. Am J Psychiatry. 2026. PMID: 42231079
OBJECTIVE: Cannabis use is a known risk factor for psychosis, but it remains unclear whether cannabis-associated psychosis (CAP) differs meaningfully from non-cannabis-associated psychosis (NCAP) in clinical presentation, biology, or illness course. The objec …
OBJECTIVE: Cannabis use is a known risk factor for psychosis, but it remains unclear whether cannabis-associated psychosis (CA …
Polygenic risk factors for comorbid diagnoses in individuals with substance use disorders: A phenome-wide survival analysis.
Barr PB, Neale ZE, Bigdeli TB, Chatzinakos C, Harvey PD, Peterson RE, Meyers JL. Barr PB, et al. Psychol Med. 2026 Jun 1;56:e174. doi: 10.1017/S003329172610470X. Psychol Med. 2026. PMID: 42219759 Free PMC article.
METHODS: Using data from All of Us (N = 393,596), we explored: (1) whether social determinants of health (SDoHs) are associated with lifetime risk of SUD (N cases = 42,568) and (2) within a subset those with a diagnosed SUD and available genetic data SUD (N = 21,357), whether PGS …
METHODS: Using data from All of Us (N = 393,596), we explored: (1) whether social determinants of health (SDoHs) are associated with lifetim …
Guidelines for the prevention of psychosis from the World Federation of Societies of Biological Psychiatry (WFSBP) and EPI Canada.
Solmi M, Correll CU, Boldrini T, Addington JM, Barbezat E, Bassetto S, Bechdolf A, Devoe D, Firth J, Paolo Fusar-Poli, Gadelha A, Göksal R, Keshavan M, Killackey E, Koutsouleris N, Lo Buglio G, Manchia M, McGorry P, Shah J, Stain HJ, Tibbo PG, Hastings T, Margolese HC, Otter N, Vieta E, Wang LJ, Woods SW, Yatham LN, Yung AR, Husain MO, Falkai P, Berk M, Carvalho AF. Solmi M, et al. World J Biol Psychiatry. 2026 Jul;27(6):509-552. doi: 10.1080/15622975.2026.2651738. Epub 2026 May 27. World J Biol Psychiatry. 2026. PMID: 42201755 Review.
At the intervention level: (x) staff should offer treatment for abstinence from cannabis, (xi) offer evidence-based treatment for comorbid mental disorders, and (xii) offer treatment for CHR-P based on patient preference, following the 'first do no harm' principle. CONCLUS …
At the intervention level: (x) staff should offer treatment for abstinence from cannabis, (xi) offer evidence-based treatment for com …
HLA Class II Immunogenetic Profiles Shape Psychosis Outcomes in Cannabis Users: DRB5/DRB1*16 Vulnerability and DRB4/DRB3-Linked Protection, Particularly Against Schizophrenia.
Buciuta A, Coman HG, Nemeș B, Cimpianu ME, Oroian R, Vică Matei ML, Matei HV. Buciuta A, et al. NeuroSci. 2026 May 7;7(3):56. doi: 10.3390/neurosci7030056. NeuroSci. 2026. PMID: 42200918 Free PMC article.
HLA-DR/DQ variation is a strong non-dopaminergic risk locus for schizophrenia, but its role in cannabis-related psychosis is unclear. METHODS: We studied 296 cannabis users from Romanian psychiatric services, grouped as non-psychosis (0), non-schizophrenia …
HLA-DR/DQ variation is a strong non-dopaminergic risk locus for schizophrenia, but its role in cannabis-related psychosis is u …
2,292 results